Resources from the same session
LBA25 - Neoadjuvant short-course radiotherapy followed by camrelizumab plus chemotherapy versus long-course chemoradiotherapy followed by chemotherapy in locally advanced rectal cancer: A randomized phase III trial (UNION)
Presenter: zhenyu lin
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
LBA26 - Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial
Presenter: Pei-Rong Ding
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA25 and LBA26
Presenter: Karin Haustermans
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Webcast
549O - Adagrasib with or without cetuximab in patients with KRASG12C-mutated colorectal cancer (CRC): Analysis of tumor biomarkers and genomic alterations
Presenter: Meredith Pelster
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
550O - Safety and efficacy of D-1553 in combination with cetuximab in KRAS G12C mutated colorectal cancer (CRC): A phase II study
Presenter: Rui-Hua Xu
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
551O - Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER
Presenter: John Strickler
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Webcast